MYC and acute myeloid leukemia: The other line, HL60 (HL-60), was initially reported to derive from a patient diagnosed with APL (Collins et al., 1978) but was later re-defined as an AML-M2-like case owing to the absence of t(15; 17) translocation and its molecular profile featuring amplification of the Myc oncogene (Dalton et al., 1988).